Leptin, insulin sensitivity and growth hormone binding protein in chronic heart failure with and without cardiac cachexia.
暂无分享,去创建一个
S. Anker | I. Godsland | M. Cicoira | C. Strasburger | K. Egerer | A. Coats | W. Doehner | V. Florea | A. Bolger | M. Rauchhaus | R. Sharma | C. Pflaum
[1] M. Volterrani,et al. Role of growth hormone in chronic heart failure: therapeutic implications. , 2000, Italian heart journal : official journal of the Italian Federation of Cardiology.
[2] W. Ricart,et al. Insulin sensitivity and secretion influence the relationship between growth hormone‐binding‐protein and leptin , 2000, Clinical endocrinology.
[3] G. Filippatos,et al. Serum leptin concentration in heart failure patients: does the literature reflect reality? , 2000, European heart journal.
[4] R. Leibel,et al. The role of leptin in human physiology. , 1999, The New England journal of medicine.
[5] D. Murdoch,et al. Inappropriately low plasma leptin concentration in the cachexia associated with chronic heart failure , 1999, Heart.
[6] S. Anker,et al. Heart failure as a metabolic problem , 1999, European journal of heart failure.
[7] Josef Niebauer,et al. Endotoxin and immune activation in chronic heart failure: a prospective cohort study , 1999, The Lancet.
[8] S. Anker,et al. Cardiac cachexia: a syndrome with impaired survival and immune and neuroendocrine activation. , 1999, Chest.
[9] E. Espiner,et al. Growth hormone binding protein correlates strongly with leptin and percentage body fat in GH-deficient adults, is increased by GH replacement but does not predict IGF-I response. , 1999, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.
[10] S. Nam,et al. GH-binding protein in obese men with varying glucose tolerance: relationship to body fat distribution, insulin secretion and the GH-IGF-I axis. , 1999, European journal of endocrinology.
[11] M. Lomsky,et al. A placebo-controlled study of growth hormone in patients with congestive heart failure. , 1998, European heart journal.
[12] J. Fernández-Real,et al. Leptin is involved in gender‐related differences in insulin sensitivity , 1998, Clinical endocrinology.
[13] S. Anker,et al. Hyperleptinaemia in chronic heart failure. Relationships with insulin. , 1998, European heart journal.
[14] F. Lönnqvist,et al. Low leptin gene expression and hyperleptinemia in chronic renal failure. , 1998, Kidney international.
[15] A. Alastrué,et al. Growth hormone-binding protein directly depends on serum leptin levels in adults with different nutritional status. , 1998, The Journal of clinical endocrinology and metabolism.
[16] P. Poole‐Wilson,et al. Randomised, double-blind, placebo-controlled trial of human recombinant growth hormone in patients with chronic heart failure due to dilated cardiomyopathy , 1998, The Lancet.
[17] S. Anker,et al. Insulin resistance in chronic heart failure: relation to severity and etiology of heart failure. , 1997, Journal of the American College of Cardiology.
[18] P. Ponikowski,et al. Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia. , 1997, Circulation.
[19] L. Carlsson,et al. Leptin levels are strongly correlated with those of GH-binding protein in prepubertal children. , 1997, European journal of endocrinology.
[20] B. Tönshoff,et al. Reduced Concentration of Serum Growth Hormone (GH)-Binding Protein in Children with Chronic Renal Failure: Correlation with GH Insensitivity , 1997 .
[21] W. Garvey,et al. The metabolic significance of leptin in humans: gender-based differences in relationship to adiposity, insulin sensitivity, and energy expenditure. , 1997, The Journal of clinical endocrinology and metabolism.
[22] P. Poole‐Wilson,et al. The influence of muscle mass, strength, fatigability and blood flow on exercise capacity in cachectic and non-cachectic patients with chronic heart failure. , 1997, European heart journal.
[23] J. Wernerman,et al. Measurement of human growth hormone receptor messenger ribonucleic acid by a quantitative polymerase chain reaction-based assay: demonstration of reduced expression after elective surgery. , 1997, The Journal of clinical endocrinology and metabolism.
[24] V. Emilsson,et al. Expression of the Functional Leptin Receptor mRNA in Pancreatic Islets and Direct Inhibitory Action of Leptin on Insulin Secretion , 1997, Diabetes.
[25] H. Orskov,et al. Abdominal fat determines growth hormone-binding protein levels in healthy nonobese adults. , 1997, The Journal of clinical endocrinology and metabolism.
[26] S. Klein,et al. Relationship Between Insulin Sensitivity and Plasma Leptin Concentration in Lean and Obese Men , 1996, Diabetes.
[27] A. Mikhail,et al. Novel B219/OB receptor isoforms: Possible role of leptin in hematopoiesis and reproduction , 1996, Nature Medicine.
[28] K. Ho,et al. Serum growth hormone-binding protein in obesity: effect of a short-term, very low calorie diet and diet-induced weight loss. , 1996, The Journal of clinical endocrinology and metabolism.
[29] J. Friedman,et al. Abnormal splicing of the leptin receptor in diabetic mice , 1996, Nature.
[30] Rene Devos,et al. Identification and expression cloning of a leptin receptor, OB-R , 1995, Cell.
[31] R. Devos,et al. Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks. , 1995, Science.
[32] M. Gourmelen,et al. Nutritional status and growth hormone-binding protein. , 1995, Hormone research.
[33] I. Godsland,et al. Assessment of insulin sensitivity in man: a comparison of minimal model- and euglycaemic clamp-derived measures in health and heart failure. , 1994, Clinical science.
[34] G. Baumann,et al. Growth hormone-binding proteins in plasma. , 1993, Nutrition.
[35] P. Kelly,et al. Evidence for generation of the growth hormone-binding protein through proteolysis of the growth hormone membrane receptor. , 1993, Endocrinology.
[36] I. Robinson,et al. Growth hormone (GH) binding protein and GH interactions in vivo in the guinea pig. , 1992, Endocrinology.
[37] M. Packer. The neurohormonal hypothesis: a theory to explain the mechanism of disease progression in heart failure. , 1992, Journal of the American College of Cardiology.
[38] I. Godsland,et al. Evaluation of four mathematical models of glucose and insulin dynamics with analysis of effects of age and obesity. , 1992, The American journal of physiology.
[39] B. Lees,et al. Sex- and menopause-associated changes in body-fat distribution. , 1992, The American journal of clinical nutrition.
[40] R. Menon,et al. Diminished growth hormone-binding protein in children with insulin-dependent diabetes mellitus. , 1992, The Journal of clinical endocrinology and metabolism.
[41] Z. Hochberg,et al. The distal axis of growth hormone (GH) in nutritional disorders: GH-binding protein, insulin-like growth factor-I (IGF-I), and IGF-I receptors in obesity and anorexia nervosa. , 1992, Metabolism: clinical and experimental.
[42] A. Rowland,et al. Ligand-mediated immunofunctional assay for quantitation of growth hormone-binding protein in human blood. , 1991, The Journal of clinical endocrinology and metabolism.
[43] J. Ketelslegers,et al. Ontogeny and nutritional regulation of the serum growth hormone-binding protein in the rat. , 1991, Acta endocrinologica.
[44] William I. Wood,et al. Growth hormone receptor and serum binding protein: purification, cloning and expression , 1987, Nature.
[45] Y. Z. Ider,et al. Quantitative estimation of insulin sensitivity. , 1979, The American journal of physiology.